Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Journal of Pediatrics|August 26, 1998
Risk of abuse of diphenhydramine in children and adolescents with chronic illnessesP A Dinndorf, M A McCabe, S FrierdichMedical and Pediatric Oncology|January 1, 1989
Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot studyJ L Finlay, M E Trigg, M P Link, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphomaP Dinndorf, M Krailo, W Liu-Mares, et al.Cancer|December 1, 1994
Excessive spinal cord toxicity from intensive central nervous system-directed therapiesJ Watterson, I Toogood, M Nieder, et al.Journal of Biological Response Modifiers|December 1, 1985
Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrowM E Trigg, P M Sondel, R Billing, et al.Cancer|June 15, 1995
A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group studyM Bauer, G H Reaman, J A Hank, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1987
Haploidentical bone marrow transplantation for osteopetrosisP J Orchard, J D Dickerman, C H Mathews, et al.Journal of Pediatric Hematology/Oncology|February 24, 2001
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group reportM S Cairo, V Shen, M D Krailo, et al.Cancer|July 15, 1997
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer GroupJ D Frost, J A Hank, G H Reaman, et al.Pageof 1